CVE-2017-18223
UnknownEPSS 0.98%
Last modified
CVE-2017-18223 is a vulnerability of currently unknown severity. BMC Remedy AR System before 9.1 SP3, when Remedy AR Authentication is enabled, allows attackers to obtain administrative access.. EPSS estimates a 0.98% chance of exploitation in the next 30 days.
Description
BMC Remedy AR System before 9.1 SP3, when Remedy AR Authentication is enabled, allows attackers to obtain administrative access.
Metrics
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Bmc | Remedy Action Request System | < 9.1.03 |
References
- https://communities.bmc.com/thread/165887Vendor Advisory
- https://communities.bmc.com/thread/165887Vendor Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2017-18223?
BMC Remedy AR System before 9.1 SP3, when Remedy AR Authentication is enabled, allows attackers to obtain administrative access.
How severe is CVE-2017-18223?
Severity scoring for CVE-2017-18223 is pending analysis. The EPSS model estimates a 0.98% probability of exploitation in the next 30 days.
How do I fix CVE-2017-18223?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2017-18223?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST